Infectious Diseases
Meningitis
Suspected acute meningitis requires parallel stabilization, prompt blood cultures and lumbar puncture when safe, and immediate empiric therapy without diagnostic delay. Cerebrospinal fluid interpretation, targeted molecular testing, host factors, and neuroimaging indications determine etiologic treatment, public-health actions, and surveillance for delayed neurologic sequelae.
Emergency management
Treat suspected acute bacterial meningitis as a time-critical syndrome
The initial objective is to obtain actionable microbiology without postponing lifesaving treatment.
Acute bacterial meningitis is a medical emergency. A compatible syndrome, particularly fever, headache, neck stiffness, and altered cognition or consciousness, should trigger urgent evaluation; the absence of all four manifestations reduces the probability of bacterial disease, but individual meningeal signs have limited sensitivity. PubMedPubMedIntroduction - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf Stabilize airway, ventilation, circulation, seizures, and shock while obtaining blood cultures and preparing for lumbar puncture (LP). PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
In hospital, administer empiric intravenous antimicrobials as early as possible. The WHO guideline identifies the first hour as the usual target window; LP and blood tests should precede therapy only when they can be completed safely without delaying treatment. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf Observational evidence associates earlier in-hospital antibiotic treatment with lower adult mortality, although a precise evidence-based cutoff remains uncertain. BMJBMJMeningitis (bacterial) and meningococcal disease: recognition, diagnosis and management—summary of updated NICE guidance
If transfer will be clinically delayed and bacterial meningitis is strongly suspected, consider parenteral prehospital therapy; if meningococcal disease is strongly suspected, give parenteral ceftriaxone or benzylpenicillin without delaying transfer. BMJBMJMeningitis (bacterial) and meningococcal disease: recognition, diagnosis and management—summary of updated NICE guidance
A rapidly progressive nonblanching petechial or purpuric rash, purpura larger than 2 mm, or meningitic symptoms plus a nonblanching rash strongly suggests meningococcal disease. BMJBMJMeningitis (bacterial) and meningococcal disease: recognition, diagnosis and management—summary of updated NICE guidance
Use immediate infection-control and public-health processes for suspected invasive meningococcal disease; close-contact prophylaxis is recommended for laboratory-confirmed sporadic cases. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Diagnosis
Use a parallel blood-CSF-microbiology strategy
Routine blood tests cannot substitute for CSF evaluation.
When LP can proceed, send CSF for Gram stain, white blood cell count and differential, protein, glucose with a paired blood glucose and CSF-to-blood glucose ratio, culture with antimicrobial susceptibility testing, and PCR-based testing for relevant pathogens. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf CSF lactate may assist differentiation of bacterial from viral meningitis before antibiotic exposure, but its value is limited after antibiotics or with competing central nervous system disorders. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
A neutrophilic pleocytosis with low CSF glucose or low CSF-to-serum glucose ratio and increased protein is the classic pyogenic pattern, but no individual CSF measure confirms or excludes meningitis. Interpret the integrated profile alongside presentation, Gram stain, cultures, and molecular testing. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf Send blood cultures as soon as possible, preferably before antibiotics. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf Peripheral leukocyte count, C-reactive protein, and procalcitonin may contribute to diagnostic probability where available but must not defer LP or treatment. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
CSF culture and susceptibility testing remain essential for bacterial identification and resistance characterization; PCR supplements rather than replaces culture. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
A positive multiplex molecular result requires clinical and CSF correlation. The U.S. FDA-cleared BioFire FilmArray ME panel detects six bacterial, seven viral, and Cryptococcus targets; pediatric survey data show widespread use but substantial variation in ordering and interpretation practices. PubMedPubMedCurrent state and practice variation in the use of Meningitis/Encephalitis (ME) FilmArray panel in children - PMC
Antibiotic exposure reduces microbiologic yield. In a five-hospital U.S. retrospective cohort, 44.4% of patients receiving antibiotics before CSF culture had received them before CSF collection, illustrating the operational importance of obtaining specimens promptly when feasible. PubMedPubMedA Ten-Year Retrospective Review of Medical Records of Patients Admitted with Meningitis or Encephalitis at Five Hospitals in the United States Highlights the Potential for Under-Ascertainment of Invasive Meningococcal Disease - PMC
| Specimen or test | Clinical role | Interpretive limitation or action |
|---|---|---|
| Blood cultures | Obtain promptly, preferably before antibiotics; may establish bacterial etiology when LP is deferred. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf | Do not delay empiric treatment to obtain cultures. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf |
| CSF Gram stain and culture with susceptibility testing | Immediate morphologic clue plus definitive bacterial identification and resistance data. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf | Negative results do not exclude disease, particularly after antimicrobial exposure. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf |
| CSF cell count, differential, protein, glucose and paired blood glucose | Defines inflammatory pattern and supports bacterial-versus-viral probability assessment. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf | No single parameter rules meningitis in or out; use age-appropriate interpretation in young children. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf |
| CSF PCR-based molecular testing | Add relevant pathogen detection, including when culture sensitivity is reduced. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf | Interpret with syndrome, CSF profile, Gram stain, and culture; do not replace culture. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf |
Lumbar puncture safety
Reserve cranial imaging before LP for features suggesting mass effect or herniation risk
Imaging is not routine before LP in suspected meningitis.
Perform cranial imaging before LP when readily accessible if the patient has GCS below 10, focal neurologic signs, cranial nerve deficits, papilledema, new-onset seizure in an adult, or severe immunocompromise. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf If imaging is not readily accessible, defer LP in patients with these features until they resolve; obtain blood cultures and start antimicrobials immediately. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
New-onset isolated seizure in a child does not independently require pre-LP cranial imaging when no other high-risk feature is present. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf Conversely, concern for hydrocephalus, mass lesion, cerebral edema, or altered consciousness should prompt neurocritical assessment and imaging once treatment has begun. PubMedPubMedIntroduction - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Do not obtain routine imaging solely because meningitis is suspected. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
A normal head CT does not create a mandate to delay therapy; treatment must proceed if LP or imaging cannot be completed promptly. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
For patients with suspected fungal meningitis after epidural anesthesia, injection, or another relevant procedure, LP may be contraindicated by puncture-site infection or a brain mass with increased intracranial pressure; involve infectious diseases urgently and do not withhold treatment solely for negative fungal cultures or beta-D-glucan. CDCCDCClinical Overview of Fungal Meningitis | Meningitis | CDC
Pharmacotherapy
Select empiric therapy by bacterial likelihood and host risk
The supplied literature supports agent selection but does not provide U.S. dosing details.
For suspected or probable acute bacterial meningitis, use intravenous ceftriaxone or cefotaxime as empiric therapy. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf Add intravenous ampicillin or amoxicillin when Listeria risk is present: age over 60 years, pregnancy, immunocompromise, transplantation, malignancy, advanced HIV disease, diabetes, end-stage kidney disease, cirrhosis, or alcohol use disorder. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf Consider intravenous vancomycin where local pneumococcal resistance to penicillin or third-generation cephalosporins is high. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Once culture and susceptibility results are available, narrow and optimize therapy. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf The supplied sources do not provide U.S. agent dosing, renal-adjustment specifications, or organism-specific treatment durations; use current local susceptibility data, institutional pathways, and prescribing references for these details.
Investigate reported beta-lactam allergy carefully: most nonsevere penicillin allergies do not preclude cephalosporin use, whereas previous life-threatening beta-lactam reactions warrant avoidance. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
In non-epidemic settings with no pathogen identified, stopping empiric antibiotics after 7 days may be considered only if the patient has clinically recovered, including sustained resolution of fever, vital-sign abnormalities, and altered mental status for at least 48 hours. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
For confirmed or strongly suspected bacterial meningitis in settings where LP can be performed, initiate intravenous corticosteroid therapy with the first antibiotic dose; discontinue if CSF is not consistent with bacterial meningitis. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Adjunctive corticosteroids
WHO recommends intravenous corticosteroids with the first antibiotic dose in suspected bacterial meningitis when LP is feasible, with discontinuation when CSF does not support bacterial meningitis. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf A NICE evidence review found corticosteroids associated with lower mortality and hearing impairment in adults and lower hearing impairment in children, although evidence quality ranged from very low to moderate. PubMedPubMedEvidence review for corticosteroids for treatment of bacterial meningitis - NCBI Bookshelf
Dexamethasone is the most studied agent, but the supplied WHO source does not provide a dose. The NICE review cites adult dexamethasone 10 mg IV every 6 hours for 4 days and pediatric dosing of 0.15 mg/kg IV every 6 hours for 4 days, but this reflects UK formulary-based guidance rather than U.S. labeling. PubMedPubMedEvidence review for corticosteroids for treatment of bacterial meningitis - NCBI Bookshelf Antibiotics should never be delayed while waiting to administer dexamethasone. PubMedPubMedEvidence review for corticosteroids for treatment of bacterial meningitis - NCBI Bookshelf
Do not routinely use corticosteroids during a meningococcal epidemic; use them in suspected or probable pneumococcal meningitis during a pneumococcal epidemic. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Do not routinely restrict fluid intake; use isotonic IV maintenance fluid when enteral hydration is not possible, and individualize restriction for suspected SIADH without hypovolemia or shock. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Do not use glycerol routinely. Hypertonic saline or mannitol may be temporizing measures for impending herniation while definitive intracranial-pressure management is arranged. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Etiology
Escalate beyond routine bacterial pathways when tempo, host factors, or exposure changes the differential
Subacute and chronic meningitides require distinct diagnostic and therapeutic pathways.
Viral meningitis is commonly self-limited, but severe disease and immunocompromise require heightened attention. In the United States, enteroviruses are leading causes; herpesviruses and influenza may have actionable antiviral treatment considerations. Most mild viral meningitis improves within 7 to 10 days, whereas severe illness or high-risk patients may require hospitalization. CDCCDCAbout Viral Meningitis
Fungal meningitis is uncommon but life-threatening. Consider it with advanced immune compromise, relevant endemic fungal exposure, or recent epidural anesthesia, injection, or invasive procedure. Fungal cultures can be negative and may take up to 2 weeks to turn positive; CDC advises immediate treatment after CSF acquisition when fungal meningitis is suspected and not withholding therapy because culture or beta-D-glucan is negative. CDCCDCClinical Overview of Fungal Meningitis | Meningitis | CDC
Tuberculous meningitis is outside routine acute bacterial pathways and often needs empiric treatment despite nondiagnostic testing. No single negative test excludes disease; CSF Xpert MTB/RIF Ultra is preferred when available, but should be paired with mycobacterial culture and clinical-imaging assessment. PubMedPubMedA Clinical Practice Guideline for Tuberculous Meningitis
For possible tuberculous meningitis, obtain baseline neuroimaging to assess hydrocephalus, infarcts, and tuberculomas; test for pulmonary tuberculosis because concurrent pulmonary disease occurs in about half of cases. PubMedPubMedA Clinical Practice Guideline for Tuberculous Meningitis
In people with HIV and possible tuberculous meningitis, cryptococcal meningitis should be urgently excluded with cryptococcal antigen testing because presentations overlap. PubMedPubMedA clinical practice guideline for tuberculous meningitis - PubMed
For suspected healthcare-associated fungal meningitis, consult infectious diseases; broad-spectrum antifungals with CNS penetration may be required, and dual or triple therapy has been used in outbreaks. CDCCDCClinical Overview of Fungal Meningitis | Meningitis | CDC
Aftercare
Plan sequelae detection before discharge, not after symptoms emerge
Delayed hearing, neurocognitive, psychiatric, and neurologic disability is common enough to justify structured follow-up.
Before discharge, assess for neurologic, sensory, functional, psychosocial, and care-support needs, and establish a documented follow-up plan. WHO recommends a clinician review for all children and adults before discharge and at least once within 4 weeks after discharge. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf Formal audiologic screening should occur before discharge or, if not feasible, within 4 weeks; even those with an initially normal screen should have repeat formal assessment because delayed hearing loss can occur. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
A 2026 systematic review and meta-analysis found meningitis-related sequelae in 18% of assessed adults and 24% of assessed children. In adults, pooled sequelae prevalence was 24.8% at discharge, 41.5% within 3 months, and 31.9% beyond 3 months; in children, pooled prevalence was 28.9% at discharge, 29.9% within 3 months, and 38.2% beyond 3 months. PubMedPubMedDetection of sequelae from acute meningitis during clinical review by a healthcare provider: a systematic review and meta-analysis - PMC These data support both discharge assessment and longitudinal reassessment rather than a single follow-up encounter.
Arrange urgent hearing rehabilitation or cochlear implantation evaluation when hearing loss is identified. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Refer promptly for rehabilitation when motor, cognitive, communication, visual, behavioral, or functional sequelae are identified. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
For acute symptomatic seizures attributable to meningitis, antiseizure therapy should generally be continued no longer than 3 months in the absence of recurrent seizures. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Common questions
Should antibiotics wait until lumbar puncture is completed?
No. Obtain blood cultures and CSF first only when this can be done safely and without clinically important delay. Start empiric intravenous antibiotics immediately if LP is deferred, imaging is needed, or diagnostic logistics delay therapy. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Which patients need head CT before lumbar puncture?
Obtain cranial imaging before LP when feasible for GCS below 10, focal neurologic signs, cranial nerve deficits, papilledema, new-onset adult seizure, or severe immunocompromise. Do not delay antimicrobial therapy for imaging. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
Can a negative molecular CSF panel rule out meningitis?
No. CSF PCR must be interpreted with clinical features, CSF indices, Gram stain, and culture. Culture and susceptibility testing remain necessary for bacterial identification and resistance characterization. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
When should survivors be screened for hearing loss?
Perform formal audiologic screening before discharge when possible; otherwise complete it within 4 weeks. Repeat testing is appropriate even after a normal initial assessment because delayed hearing loss can occur. PubMedPubMedExecutive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf
References
- Viral meningitis - Symptoms, diagnosis and treatment — bestpractice.bmj.com · bestpractice.bmj.com
- Meningitis (bacterial) and meningococcal disease — www.bmj.com · www.bmj.com
- Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management—summary of updated NICE guidance — www.bmj.com · www.bmj.com
- Bacterial meningitis - Symptoms, diagnosis and treatment | BMJ Best Practice US — bestpractice.bmj.com · bestpractice.bmj.com
- Practice Guidelines for the Management of Bacterial Meningitis — academic.oup.com · academic.oup.com
- Tuberculous meningitis: does lowering the treatment threshold ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Diagnosis and Management of Bacterial Meningitis in the ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Meningitis in adults: diagnosis and management - Young — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- A Clinical Practice Guideline for Tuberculous Meningitis — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- A clinical practice guideline for tuberculous meningitis - PubMed — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
- Detection of sequelae from acute meningitis during clinical review by a healthcare provider: a systematic review and meta-analysis - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- A Ten-Year Retrospective Review of Medical Records of Patients Admitted with Meningitis or Encephalitis at Five Hospitals in the United States Highlights the Potential for Under-Ascertainment of Invasive Meningococcal Disease - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Current state and practice variation in the use of Meningitis/Encephalitis (ME) FilmArray panel in children - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Executive summary - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Guideline development teams - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Introduction - WHO guidelines on meningitis diagnosis, treatment and care - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Evidence review for corticosteroids for treatment of bacterial meningitis - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Clinical Overview of Fungal Meningitis | Meningitis | CDC — www.cdc.gov · www.cdc.gov
- Community-acquired bacterial meningitis in adults with ... — www.neurology.org · www.neurology.org
- About Meningitis — www.cdc.gov · www.cdc.gov
- About Fungal Meningitis | Meningitis | CDC — www.cdc.gov · www.cdc.gov
- Study Details | NCT03759470 | Evaluation of Different Methods for Diagnosis of ME | ClinicalTrials.gov — clinicaltrials.gov · clinicaltrials.gov
- Laboratory Methods for the Diagnosis of Meningitis ... — stacks.cdc.gov · stacks.cdc.gov
- About Viral Meningitis — www.cdc.gov · www.cdc.gov